Adoptive immunotherapy of syngeneic murine leukemia is enhanced by the combination of recombinant IFN-gamma and a tumor-specific cytotoxic T cell clone.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples